| 14.12 0 (0.17%) | 05-12 12:07 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 16.85 | 1-year : | 17.25 |
| Resists | First : | 14.43 | Second : | 14.76 |
| Pivot price | 14.14  |
|||
| Supports | First : | 13.89 | Second : | 11.55 |
| MAs | MA(5) : | 14.15 |
MA(20) : | 14.24 |
| MA(100) : | 14.49 |
MA(250) : | 13.97 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 36.5 |
D(3) : | 33.5 |
| RSI | RSI(14): 48.7 |
|||
| 52-week | High : | 15.43 | Low : | 12.68 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ BMEZ ] has closed below upper band by 44.5%. Bollinger Bands are 45.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 14.23 - 14.3 | 14.3 - 14.36 |
| Low: | 13.9 - 13.98 | 13.98 - 14.04 |
| Close: | 14.01 - 14.13 | 14.13 - 14.23 |
BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.
Sun, 22 Mar 2026
BMEZ: Sell, Distributions Down 34% And Undercovered (NYSE:BMEZ) - Seeking Alpha
Tue, 23 Dec 2025
Fairbairn sells BlackRock Health Sciences (BMEZ) stock for $308k By Investing.com - Investing.com Australia
Mon, 22 Dec 2025
Fairbairn sells BlackRock Health Sciences (BMEZ) stock for $308k - Investing.com
Sat, 30 Aug 2025
BlackRock Health Sciences Term Trust Q2 2025 Commentary (BMEZ) - Seeking Alpha
Thu, 24 Apr 2025
BMEZ Stock Price, News & Analysis - Stock Titan
Thu, 27 Feb 2025
15 Years of PCEF: An ETF of CEFs - ETF Trends
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 63 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 21.5 (%) |
| Shares Short | 66 (K) |
| Shares Short P.Month | 36 (K) |
| EPS | 2.53 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 5.57 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0.1 |
| Forward Dividend | 0 |
| Dividend Yield | 0.7% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|